Platelet histogram indices and cardiovascular disease in patients with rheumatoid arthritis

C Jurcuţ1, Ruxandra Jurcuţ, Simona Caraiola

  • 1Internal Medicine Department, "Dr. Carol Davila" Central University Emergency Military Hospital, Bucharest, Romania. cjurcut@gmail.com

Insights

Rheumatoid arthritis patients with cardiovascular disease show increased platelet activation, indicated by higher mean platelet volume (MPV) and platelet distribution width (PDW). These platelet indices may help identify heightened prothrombotic activity in RA patients at risk for CVD.

Area of Science:

  • Rheumatology
  • Cardiology
  • Hematology

Background:

  • Rheumatoid arthritis (RA) is associated with a higher prevalence of cardiovascular disease (CVD) compared to the general population.
  • Predictors for CVD development in RA patients and the role of thrombosis mechanisms remain incompletely understood.
  • Platelet activation markers may offer insights into the pathogenesis of CVD in RA.

Purpose of the Study:

  • To investigate platelet histogram indices, specifically mean platelet volume (MPV) and platelet distribution width (PDW), as markers of platelet activation.
  • To compare these indices in patients with RA with and without CVD.
  • To evaluate the association of platelet indices with CVD in RA patients.

Main Methods:

  • A study involving 64 patients with RA, assessing clinical and biochemical parameters, including platelet histogram analysis (MPV, PDW).
  • Patients were divided into two groups: RA without CVD (n=41) and RA with CVD (n=23).
  • Comparisons were made with a control group (n=20) and a group of patients with CVD without RA (n=62).

Main Results:

  • Patients with RA and CVD exhibited significantly higher MPV and PDW values compared to RA patients without CVD, indicating greater platelet activation.
  • PDW values were higher in RA patients with CVD than in patients with CVD but without RA, suggesting increased platelet activation in RA.
  • PDW correlated with fibrinogen levels, but not with CRP or ESR, while MPV did not correlate with inflammatory markers in RA patients.

Conclusions:

  • The pathogenesis of CVD in rheumatoid arthritis patients may involve increased prothrombotic activity.
  • Platelet histogram indices, such as MPV and PDW, may serve as valuable indicators of this heightened prothrombotic state.
  • These findings suggest that platelet activation markers could aid in assessing CVD risk in RA.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...